The misuse of GLP-1 drugs without clinical oversight can lead to severe health complications. GLP-1 receptor agonist drugs carry serious side effects ranging from nausea and vomiting to pancreatitis, acute kidney injury, bowel obstruction, and medullary thyroid cancer, the Ministry of Health and Family Welfare warned on 1 April, 2026
In 2025, a landmark study revealed that patients with severe obesity lost an average of 11.9% of their body weight after a year of consistent injectable therapies like semaglutide
cAMP accumulation assay CHOFlpIn WT GLP-1R or CHOFlpIn mutant GLP-1R cells were seeded at a density of 30,000 cells per well into a 96-well plate and incubated overnight at 37 C in 5% CO 2
Nagar Uttar Pradesh, India Marketer details Name: Mishima Enterprises Address: Ground Floor, Jajmau, Pokharpur, A.No.22, Plot No.6, Kanpur, Kanpur Nagar, Uttar Pradesh, 208010 Vendor Details Country of origin: India 2403 MRP 2669.4910% off Save more with additional offers Get up to 75 cashback on a minimum order value (MOV) of 499 and above, valid once per customer
Adenomyosis: epidemiology, risk factors, clinical phenotype and surgical and interventional alternatives to hysterectomy